Abnormal fibrillin-1 expression and chronic oxidative stress mediate endothelial mesenchymal transition in a murine model of systemic sclerosis.
about
Transient repetitive exposure to low level light therapy enhances collateral blood vessel growth in the ischemic hindlimb of the tight skin mouse.4F decreases IRF5 expression and activation in hearts of tight skin mice.Angiotensin II induces skin fibrosis: a novel mouse model of dermal fibrosisUpdates on morphea: role of vascular injury and advances in treatment.Systemic sclerosis sera affect fibrillin-1 deposition by dermal blood microvascular endothelial cells: therapeutic implications of cyclophosphamide.The role of endothelial-mesenchymal transition in development and pathological process.A vascular mechanistic approach to understanding Raynaud phenomenon.A system out of breath: how hypoxia possibly contributes to the pathogenesis of systemic sclerosis.The impact of transcription factor Fli1 deficiency on the regulation of angiogenesis.Fluorescence Imaging of Interscapular Brown Adipose Tissue in Living Mice.Constitutively active Notch1 signaling promotes endothelial‑mesenchymal transition in a conditional transgenic mouse modelSalvianolic Acid A, a Component of Salvia miltiorrhiza, Attenuates Endothelial-Mesenchymal Transition of HPAECs Induced by Hypoxia.Role of tetrahydrobiopterin in pulmonary vascular remodelling associated with pulmonary fibrosis.Rationale and design of DUAL study: Doxycycline to Upgrade response in light chain (AL) amyloidosis (DUAL): A phase 2 pilot study of a two-pronged approach of prolonged doxycycline with plasma cell-directed therapy in the treatment of AL amyloidosisA Potential Link Between Oxidative Stress and Endothelial-to-Mesenchymal Transition in Systemic SclerosisAn orally-active adiponectin receptor agonist mitigates cutaneous fibrosis, inflammation and microvascular pathology in a murine model of systemic sclerosis
P2860
Q34508585-C87DBCE4-1DF9-487A-A426-B76FF44B332AQ34517543-CC966172-3042-45AB-A9DF-927C379112CAQ36633452-FAF9DD5A-000F-46D6-89CE-56D023C43EBCQ37351546-A6D244B0-9DCB-49DF-AD2F-DAE851AE321FQ37690207-E22A8969-AE06-4F74-B2EA-E5E6AAA469CAQ38021441-19CB3DBF-9A04-451F-9026-F9E45583F9E2Q38299133-2721BE6E-4F98-43DA-ABCD-A2D66B3F621AQ39519878-C19575C2-3786-4E14-B57A-AE4DB929842AQ40261100-24D68DA8-FFBD-40AC-9DC1-AE09E7DE689EQ41000170-64131957-F749-46BF-BAF5-160EF117E4E2Q42768111-9C541D8B-9C72-43B6-B122-8B9AA43491A0Q46308858-03B0272D-2E67-40C7-8F0A-86BE93E9A780Q50934553-DD761F2D-CB3D-46AE-B5A8-E7C393773EDEQ52716575-26792301-46D5-4509-8E73-AB66ED70AF1FQ57072741-F3A38D0F-118D-400D-AA45-A353243E1E03Q58797878-E72885D2-17F3-4249-8FD8-6863EFAF112F
P2860
Abnormal fibrillin-1 expression and chronic oxidative stress mediate endothelial mesenchymal transition in a murine model of systemic sclerosis.
description
2010 nî lūn-bûn
@nan
2010 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Abnormal fibrillin-1 expressio ...... e model of systemic sclerosis.
@ast
Abnormal fibrillin-1 expressio ...... e model of systemic sclerosis.
@en
Abnormal fibrillin-1 expressio ...... e model of systemic sclerosis.
@nl
type
label
Abnormal fibrillin-1 expressio ...... e model of systemic sclerosis.
@ast
Abnormal fibrillin-1 expressio ...... e model of systemic sclerosis.
@en
Abnormal fibrillin-1 expressio ...... e model of systemic sclerosis.
@nl
prefLabel
Abnormal fibrillin-1 expressio ...... e model of systemic sclerosis.
@ast
Abnormal fibrillin-1 expressio ...... e model of systemic sclerosis.
@en
Abnormal fibrillin-1 expressio ...... e model of systemic sclerosis.
@nl
P2093
P2860
P1476
Abnormal fibrillin-1 expressio ...... e model of systemic sclerosis.
@en
P2093
Ashish Gadicherla
Deron W Jones
Dorothée Weihrauch
Janine Struve
John G Krolikowski
Kirkwood A Pritchard
Maria Zaidi
Mary Ellen Csuka
Nicole L Lohr
P2860
P304
P356
10.1152/AJPCELL.00123.2010
P577
2010-12-15T00:00:00Z